InvestorIdeas.com | big ideas for the small cap investor

search subscribe advertise submitnews

   research       membership       insiders corner       investor alerts       audio       marketplace       green investor       stock directories       trading center       JOBS     

Pfizer Takes Painkiller Bextra Off Market

Pfizer Takes Bextra Off Market; FDA Wants Strongest Warnings on Other Painkillers in Same Class

WASHINGTON -- The painkiller Bextra was taken off the market Thursday, and the government wants other drugs in the same class to carry the strongest possible warnings about increased risk of heart attack and stroke among the millions of people who rely on them.

Pfizer Inc. suspended sales of Bextra in the United States and the European Union at the request of the Food and Drug Administration and European regulators. The company said the FDA, in seeking its withdrawal, cited a risk of serious skin reactions to Bextra.

For Full Article Click Here:



TOP

ECON Corporate Services, Inc.

© 2000 - 2008 InvestorIdeas.com®, ECON

about us | partners / links | company showcase | contact | employment | disclaimer | privacy policy | sitemap